South Korea Veterinary Contract Manufacturing & Research Market (2026-2031)
The South Korea Veterinary Contract Manufacturing & Research Market was valued at $15 Million in 2026 and projected to reach to $23.5 Million by 2031, representing a compound annual growth rate of 9.4%. South Korea's veterinary contract manufacturing and research market is poised for significant expansion, driven by increasing demand for specialized animal health solutions across Asia-Pacific.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Veterinary Contract Manufacturing & Research Market Trends and Insights
- This growth trajectory reflects South Korea's strengthening position as a regional hub for advanced veterinary pharmaceutical development and manufacturing capabilities.
- South Korea's investment in biotechnology infrastructure and regulatory frameworks has positioned the country to capture increasing demand from regional and international veterinary pharmaceutical companies seeking specialized contract manufacturing and research services. The market in South Korea is driven by rising pet ownership, increased spending on animal healthcare, and growing adoption of advanced veterinary therapeutics across the Asia Pacific region.
- South Korea's skilled workforce, state-of-the-art manufacturing facilities, and proximity to major Asian markets create competitive advantages for contract manufacturers and research organizations.
- Between 2026 and 2031, South Korea is expected to benefit from consolidation trends in the global veterinary pharmaceutical industry, with multinational companies increasingly outsourcing manufacturing and research functions to specialized regional partners..
Key Market Statistics
- CAGR (2026-2031) 9.4% CAGR
- Market Size, 2026 ~USD 15 Million
- Forecast, 2031 ~USD 23.5 Million
- Country South Korea
South Korea Veterinary Contract Manufacturing & Research Market Overview
Strong CAGR Growth :
South Korea's veterinary contract manufacturing market is expanding at 9.4% CAGR from 2026-2031, outpacing the global average of 7.7%, demonstrating accelerating regional demand and investment.
Biotech Hub Development :
South Korea is establishing itself as a regional center for advanced veterinary pharmaceutical development, leveraging government support for biotechnology infrastructure and R&D capabilities.
Market Valuation Growth :
The market is projected to grow from $15.0 million in 2026 to $23.5 million by 2031, representing a 56.7% increase in market value over the five-year forecast period.
Regional Manufacturing Leadership :
South Korea's strategic position in Asia-Pacific, combined with advanced manufacturing standards and regulatory expertise, positions it as a preferred outsourcing destination for veterinary pharmaceutical companies.
South Korea Veterinary Contract Manufacturing & Research Market Dynamics
- The country's robust biotechnology infrastructure, government incentives for pharmaceutical development, and skilled workforce are attracting both domestic and international veterinary pharmaceutical companies seeking reliable manufacturing partners.
- Growing pet ownership, livestock health concerns, and regulatory harmonization efforts further support market expansion.
- By 2031, South Korea is expected to solidify its position as a leading regional hub for veterinary contract manufacturing, with enhanced capabilities in biologics, vaccines, and specialized formulations..
Related Ecosystem
Animal Health
Key Takeaways
- South Korea's veterinary contract manufacturing market is valued at $15.0 million in 2026 and is forecast to grow to $23.5 million by 2031, representing a 9.4% CAGR.
- South Korea's advanced biotechnology infrastructure and skilled workforce position it as a preferred outsourcing destination for regional and global veterinary pharmaceutical companies.
- Rising pet ownership and increased animal healthcare spending across Asia Pacific are driving demand for South Korea's contract manufacturing and research services.
- South Korea is expected to capture significant market share through 2031 as multinational veterinary pharmaceutical companies consolidate and expand outsourcing partnerships in the region.
Veterinary Contract Manufacturing & Research Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CDMO SERVICES (Service) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CDMO SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 6.38 (2026) |
| Revenue Forecast (Billions) | ~USD 9.24 (2031) |
| Segments Covered | Service, Type |
South Korea Veterinary Contract Manufacturing & Research Market Report Segmentation
2 segment dimensions are covered across the global market.
By Service
- Cdmo Services
- Cro Services
By Type
- Analytical & Bioanalytical Services And Quality Assurance
- Discovery & Pre-Clinical Studies
- Manufacturing
- Packaging & Labeling
- Process Api & Formulation Development
- Quality/Stability & Post-Market Support
- Regulatory Affairs & Consulting
- Veterinary Clinical Trials
Target Audience
- Veterinary Pharmaceutical Companies : Evaluate South Korea as a contract manufacturing destination, assess outsourcing opportunities, and identify local partners for cost-effective production and regional distribution.
- Contract Research Organizations (CROs) : Understand market demand for veterinary research services in South Korea, identify expansion opportunities, and benchmark service offerings against regional competitors.
- Investment & Private Equity Firms : Assess investment potential in South Korea's veterinary biotech sector, identify acquisition targets, and evaluate growth prospects for portfolio companies in animal health manufacturing.
- Government & Trade Organizations : Support policy development, trade initiatives, and industry promotion strategies by understanding South Korea's veterinary manufacturing capabilities and competitive advantages.
- Equipment & Supply Vendors : Identify market opportunities for manufacturing equipment, raw materials, and specialized supplies by understanding South Korea's production capacity expansion and technology adoption trends.
Reasons to Buy this Report
- Market Entry Strategy : Identify optimal entry points and partnership opportunities in South Korea's rapidly growing veterinary manufacturing sector with detailed competitive landscape and regulatory pathway analysis.
- Investment Decision Support : Make informed capital allocation decisions with comprehensive market sizing, growth projections, and profitability indicators specific to South Korea's veterinary contract manufacturing segment.
- Competitive Benchmarking : Understand South Korea's market positioning relative to global trends, identify emerging competitors, and assess your competitive advantage in this high-growth regional market.
- Demand Forecasting : Leverage detailed 2026-2031 projections to forecast demand for veterinary manufacturing services, plan capacity expansion, and align production capabilities with market growth trajectories.
- Regulatory & Operational Insights : Access South Korea-specific regulatory requirements, manufacturing standards, and operational best practices essential for successful market participation and compliance.
Frequently asked questions
What is the current market size of veterinary contract manufacturing in South Korea?
South Korea's veterinary contract manufacturing and research market is valued at $15.0 million in 2026 and is projected to reach $23.5 million by 2031.
What is the expected growth rate for South Korea's veterinary contract manufacturing market?
South Korea's veterinary contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2031.
Why is South Korea becoming a hub for veterinary contract manufacturing?
South Korea's advanced biotechnology infrastructure, skilled workforce, strong regulatory frameworks, and strategic location in Asia Pacific make it an attractive destination for veterinary pharmaceutical contract manufacturing and research outsourcing.
What factors are driving growth in South Korea's veterinary market?
Key growth drivers in South Korea include rising pet ownership, increased animal healthcare spending, growing adoption of advanced veterinary therapeutics, and consolidation trends among global veterinary pharmaceutical companies seeking regional outsourcing partners.
How does South Korea's market compare to the global veterinary contract manufacturing market?
South Korea's veterinary contract manufacturing market is growing at 9.4% CAGR, outpacing the global market growth rate of 7.7%, reflecting the country's strategic importance as a regional manufacturing and research hub.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product/service managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.
Market Definition
The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.
These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.
Key Stakeholders
- Animal-health pharmaceutical companies
- Veterinary biotechnology companies
- Veterinary biologics & vaccine developers
- Veterinary contract development & manufacturing organizations (CDMOs)
- Veterinary contract research organizations (CROs)
- Preclinical & toxicology research laboratories (GLP & non-GLP)
- Clinical trial management organizations for veterinary studies
- Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
- Quality control & analytical testing laboratories (veterinary-focused)
- Veterinary formulation & process development service providers
- Packaging, filling, and labeling service providers for veterinary products
- Animal research facilities & field trial centers
- Veterinary academic research institutes
- Livestock research institutions & herd-health trial networks
- Raw material suppliers for veterinary APIs, excipients, and biologics components
Report Objectives
- To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
- Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
- Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
- Competitive leadership mapping for established players in the US
Get the Full Veterinary Contract Manufacturing & Research Market Report
Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.
- US Veterinary Contract Manufacturing & Research Market
- Canada Veterinary Contract Manufacturing & Research Market
- Mexico Veterinary Contract Manufacturing & Research Market
- Brazil Veterinary Contract Manufacturing & Research Market
- Argentina Veterinary Contract Manufacturing & Research Market
- Germany Veterinary Contract Manufacturing & Research Market
- UK Veterinary Contract Manufacturing & Research Market
- France Veterinary Contract Manufacturing & Research Market
- Italy Veterinary Contract Manufacturing & Research Market
- Spain Veterinary Contract Manufacturing & Research Market
- Netherlands Veterinary Contract Manufacturing & Research Market
- China Veterinary Contract Manufacturing & Research Market
- Japan Veterinary Contract Manufacturing & Research Market
- India Veterinary Contract Manufacturing & Research Market
- Australia Veterinary Contract Manufacturing & Research Market
- Thailand Veterinary Contract Manufacturing & Research Market
- New Zealand Veterinary Contract Manufacturing & Research Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report